Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

295.71 -2.57 (-0.86%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
32 33 Next >
Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says
Piper Sandler has initiated coverage on Cigna, highlighting its strong position in the specialty pharmacy market and robust growth in the Cigna Healthcare and Evernorth Health Services businesses. 
Via Benzinga
What Analysts Are Saying About Cigna Group Stock
Via Benzinga
Here's How Much $1000 Invested In Cigna Group 5 Years Ago Would Be Worth Today
Via Benzinga
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Commanding incredible relevancy, these strong buy healthcare stocks should be on every investor’s watch list. 
Via InvestorPlace
NYSE:CI appears to be flying under the radar despite its strong fundamentals.
For those who appreciate value investing, THE CIGNA GROUP (NYSE:CI) is a compelling option with its solid fundamentals. 
Via Chartmill
10 Value Stocks With Low Debt And Strong Growth
One of the problems we are facing as a value investor is an extremely high stock market and an aberrantly long-running bull market. It’s one of the longest in recorded history. 
Via Talk Markets
Despite its growth, NYSE:CI remains within the realm of affordability.
In the world of growth stocks, NYSE:CI shines as a value proposition. 
Via Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today
Via Benzinga
Forecasting The Future: 12 Analyst Projections For Cigna Group
Via Benzinga
Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support
Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support 
Via News Direct
Topics Artificial Intelligence
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance... 
Via Benzinga
Top-rated Medicaid Practice, Denver Youth Dentistry and Orthodontics Removes Barriers to Quality Dental Care for Children in Denver
Via Get News
Class Lawsuit Alleges Cigna Discriminates by Excluding Obesity Drugs
June 05, 2024 -- Nation's First Lawsuit Asserting that the Affordable Care Act Forbids Exclusion of Obesity Treatment 
Via 24-7 Press Release
Topics Lawsuit
Centene Reaffirms Guidance, But Is it Too Late?
Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came 
Via MarketBeat
NYSE:CI, a growth stock which is not overvalued.
THE CIGNA GROUP (NYSE:CI) is not too expensive for the growth it is showing. 
Via Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,800 Today
Via Benzinga
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Cigna looks like a shining star as many health insurance companies fare poorly in 2024 due to higher Medicare Advantage (MA) expenses 
Via MarketBeat
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?
The major market indexes keep hitting new highs, but these stocks haven't participated in the bull run. 
Via The Motley Fool
NYSE:CI is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
THE CIGNA GROUP (NYSE:CI) is an undervalued gem with solid fundamentals. 
Via Chartmill
Gravy Train Investing
Today, let’s discuss policy investing. Or, if you prefer, feel free to call it “gravy train investing.” And it can be very profitable. 
Via Talk Markets
Cigna Stock Hovers Near All-time High Amid Healthy Profit Growth
Cigna stock is building a flat base with a 365.71 buy point., which is also its all-time high, set on March 28. 
Via Investor's Business Daily
Looking Into Cigna Group's Recent Short Interest
Via Benzinga
Buffett’s Best Bets: 3 Must-Have Stocks in the Oracle’s Arsenal
Chubb, Liberty Media and Bank of America are three Warren Buffett stocks to buy for investors seeking long-term opportunities. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
How to Win in Business: Be Right, Be Positive
Author Elliott Parker helps us think about how to spot the difference between world-changing innovations and corporate theater. 
Via The Motley Fool
NYSE:CI stands out as a stock that provides good value for the fundamentals it showcases.
THE CIGNA GROUP (NYSE:CI) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains. 
Via Benzinga
Topics Economy
Cigna Group (CI) Q1 2024 Earnings Call Transcript
CI earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Cigna Crushes Q1 Estimates: Revenue Soars With Evernorth's Explosive Growth
Cigna beats sales expectations with a 23% Y/Y increase to $57.26 billion, driven by Evernorth Health Services' growth and strong contributions from Cigna Healthcare. Explore financial insights and... 
Via Benzinga
CI Stock Earnings: Cigna Group Beats EPS, Beats Revenue for Q1 2024
CI stock results show that Cigna Group beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.